Overview Safety of Insulin Detemir for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes Mellitus Status: Completed Trial end date: 2006-04-01 Target enrollment: Participant gender: Summary This trial is conducted in North America. The aim of this trial is to evaluate the safety of insulin detemir for the treatment of diabetes. Phase: Phase 3 Details Lead Sponsor: Novo Nordisk A/STreatments: InsulinInsulin DetemirInsulin, Globin Zinc